HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme

被引:168
作者
Miyata, N [1 ]
Taniguchi, K [1 ]
Seki, T [1 ]
Ishimoto, T [1 ]
Sato-Watanabe, M [1 ]
Yasuda, Y [1 ]
Doi, M [1 ]
Kametani, S [1 ]
Tomishima, Y [1 ]
Ueki, T [1 ]
Sato, M [1 ]
Kameo, K [1 ]
机构
[1] Taisho Pharmaceut Co Ltd, Med Res Labs, Ohmiya, Saitama 3308530, Japan
关键词
20-HETE; cytochrome P4504A; HET0016; kidney; EETs;
D O I
10.1038/sj.bjp.0704101
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study examined the inhibitory effects of N-Hydroxy-N '-(4-butyl-2-methylphenyl)-formamidine (HET0016) on the renal metabolism of arachidonic acid by cytochrome P450 (CYP) enzymes. HET0016 exhibited a high degree of selectivity in inhibiting the formation of 20-hydroxy-5,8,11,14-eicosatetraenoic acid (20-HETE) in rat renal microsomes. The IC50 value averaged 35 +/-4 nM, whereas the IC50 value for inhibition of the formation of epoxyeicosatrienoic acids by HET0016 averaged 2800 +/- 300 nM. In human renal microsomes, HET0016 potently inhibited the formation of 20-HETE with an IC50 value of 8.9 +/-2.7 nM. Higher concentrations of HET0016 also inhibited the CYP2C9, CYP2D6 and CYP3A4-catalysed substrates oxidation with IC50 values of 3300, 83,900 and 71,000 nM. The IC50 value for HET0016 on cyclo-oxygenase activity was 2300 nM. These results indicate that HET0016 is a potent and selective inhibitor of CYP enzymes responsible for the formation of 20-HETE in man and rat.
引用
收藏
页码:325 / 329
页数:5
相关论文
共 23 条
[21]   Inhibition of renal arachidonic acid ω-hydroxylase activity with ABT reduces blood pressure in the SHR [J].
Su, P ;
Kaushal, KM ;
Kroetz, DL .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1998, 275 (02) :R426-R438
[22]  
Wang MH, 1998, J PHARMACOL EXP THER, V284, P966
[23]  
ZOU AP, 1994, J PHARMACOL EXP THER, V268, P474